From acquisitions to quarterly updates, here are seven key developments from spine and orthopedic devicemakers since Jan. 22.
1. Stryker is selling its U.S. spinal implant business to Viscogliosi Brothers. Stryker also reported $6.4 billion in net sales during the fourth quarter of 2024.
2. Neuralink enlisted The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami (Fla.) Miller School of Medicine as the second site of its PRIME study.
3. NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts.
4. Saluda Medical earned FDA approval for its biomarker-based automated patient programming platform used in spinal cord stimulation.
5. Centinel Spine saw prodisc revenue surpass $95 million in 2024.
6. Aurora Spine promoted two executive leaders. Matt Paxton was named executive vice president of sales, and Katelyn Sims is now area vice president of commercialization and key accounts.
7. Zimmer Biomet acquired orthopedic company Paragon 28.